Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

Fragmin/ Dalteparin Sodium

Pre-filled syringes containing a single dose of 5000 IU Fragmin/ Dalteparin Sodium.

DRUG

Placebo for Fragmin/ Dalteparin Sodium

Pre-filled syringes containing a single dose of placebo for 5000 IU Fragmin/ Dalteparin Sodium.

Trial Locations (63)

2400

Pfizer Investigational Site, Koebenhavn NV

2650

Pfizer Investigational Site, Hvidovre

3103

Pfizer Investigational Site, Tønsberg

5000

Pfizer Investigational Site, Odense C

6043

Pfizer Investigational Site, Ransart

6400

Pfizer Investigational Site, Sønderborg

8000

Pfizer Investigational Site, Aarhus C

9100

Pfizer Investigational Site, Aalborg

10207

Pfizer Investigational Site, Vilnius

11527

Pfizer Investigational Site, Athens

11883

Pfizer Investigational Site, Stockholm

15127

Pfizer Investigational Site, Melissia/Athens

17007

Pfizer Investigational Site, Girona

17176

Pfizer Investigational Site, Stockholm

18288

Pfizer Investigational Site, Stockholm

28040

Pfizer Investigational Site, Madrid

28905

Pfizer Investigational Site, Getafe

33520

Pfizer Investigational Site, Tampere

49476

Pfizer Investigational Site, Kaunas

50139

Pfizer Investigational Site, Florence

56124

Pfizer Investigational Site, Pisa

56429

Pfizer Investigational Site, Thessaloniki

61002

Pfizer Investigational Site, Kharkiv

65009

Pfizer Investigational Site, Odesa

71013

Pfizer Investigational Site, San Giovanni Rotondo

76307

Pfizer Investigational Site, Karlsbad

79010

Pfizer Investigational Site, Lviv

109240

Pfizer Investigational Site, Moscow

115998

Pfizer Investigational Site, Moscow

119034

Pfizer Investigational Site, Moscow

123423

Pfizer Investigational Site, Moscow

127486

Pfizer Investigational Site, Moscow

194156

Pfizer Investigational Site, Saint Petersburg

A-9020

Pfizer Investigational Site, Klagenfurt

A-1030

Pfizer Investigational Site, Vienna

A-1090

Pfizer Investigational Site, Vienna

R3A 1R9

Pfizer Investigational Site, Winnipeg

H1T 2M4

Pfizer Investigational Site, Montreal

140 21

Pfizer Investigational Site, Prague

150 06

Pfizer Investigational Site, Prague

760 01

Pfizer Investigational Site, Zlín

106 76

Pfizer Investigational Site, Athens

00133

Pfizer Investigational Site, Roma

01102

Pfizer Investigational Site, Vilnius

80-952

Pfizer Investigational Site, Gdansk

90-153

Pfizer Investigational Site, Lodz

24-100

Pfizer Investigational Site, Puławy

02-097

Pfizer Investigational Site, Warsaw

51-124

Pfizer Investigational Site, Wroclaw

651 85

Pfizer Investigational Site, Karlstad

205 02

Pfizer Investigational Site, Malmo

141 86

Pfizer Investigational Site, Stockholm

182 88

Pfizer Investigational Site, Stockholm

02091

Pfizer Investigational Site, Kyiv

S75 2EP

Pfizer Investigational Site, Barnsley

B9 5SS

Pfizer Investigational Site, Birmingham

CO4 5JL

Pfizer Investigational Site, Colchester

CV2 2DX

Pfizer Investigational Site, Coventry

DD1 9SY

Pfizer Investigational Site, Dundee

IP4 5PD

Pfizer Investigational Site, Ipswich

M13 0JE

Pfizer Investigational Site, Manchester

M13 9WL

Pfizer Investigational Site, Manchester

PE3 9GZ

Pfizer Investigational Site, Peterborough

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY